Comprehensively mapping and decoding the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes
| Website | http://immunai.com |
| Revenue | $29.4 million |
| Employees | 177 (152 on RocketReach) |
| Founded | 2019 |
| Address | 180 Varick Street, New York, New York, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+33 more
(view full list)
|
| Industry | Biotechnology Research, Analytics, Biotechnology, Data and Analytics, Artificial Intelligence, Science and Engineering, Software |
| Keywords | Cell Therapy, Artificial Intelligence, Immune System, Ai Drug Discovery, Biotechnology Research, Therapeutic Discovery, Precision Medicine, Immunotherapy, Biotechnology, Drug Development, Machine Learning, Data-Driven Healthcare, Patient Outcomes, Clinical Trials, Bioinformatics, Genomics, Immunology Research, Pharmaceutical Research, Healthcare Technology |
| Competitors | Bristol Myers Squibb, Illumina, Tempus Labs, Inc., Guardant Health, GRAIL, Foundation Medicine, 10x Genomics, Adaptive Biotechnologies Corp., Cell Signaling Technology (CST), Cellarity +45 more (view full list) |
Looking for a particular Immunai employee's phone or email?
The Immunai annual revenue was $29.4 million in 2026.
Adeeb Rahman is the CTO of Immunai.
152 people are employed at Immunai.
Immunai is based in New York, New York.